Imbruvica 140 mg Capsule
4.941,07$
4.138,71$
Imbruvica 140 mg capsules are a targeted therapy designed to combat specific types of adult blood cancers, including mantle cell lymphoma (MCL), chronic lymphocytic leukemia (CLL), and Waldenström's macroglobulinemia (WM). The active ingredient in Imbruvica works by effectively blocking protein kinase activity, which plays a crucial role in cancer cell survival and proliferation. By disrupting these cellular signals, Imbruvica helps to halt the growth of malignant cells, offering hope to those battling these challenging conditions. It is essential for patients to discuss any underlying health issues with their healthcare provider, as Imbruvica may come with certain warnings, including potential side effects and interactions with other medications. Regular monitoring during treatment is advised to ensure the best outcomes and manage any adverse effects. This innovative therapy represents a significant advancement in the treatment landscape for blood cancers, providing patients with a new avenue for effective management of their disease. Always consult your doctor for tailored advice and to determine if Imbruvica is the right choice for your treatment plan.
Cantidad
Active Pharmaceutical Ingredient
Uses
• Imbruvica 140 mg capsule is primarily used to treat chronic lymphocytic leukemia (CLL), a type of cancer that affects the blood and bone marrow. It helps to slow the progression of the disease by targeting specific pathways involved in cancer cell growth. Patients receiving Imbruvica often experience a reduction in lymphocyte counts, which can lead to improved overall health. This medication is particularly beneficial for individuals who have received prior treatments.
• In addition to CLL, Imbruvica 140 mg capsule is effective in treating mantle cell lymphoma (MCL). MCL is a rare and aggressive form of non-Hodgkin lymphoma that can be challenging to manage. By inhibiting certain proteins that promote cancer cell survival, Imbruvica provides patients with a valuable option for controlling this disease. Many patients see a meaningful response to treatment, leading to extended periods of remission.
• Imbruvica 140 mg capsule is also indicated for the treatment of Waldenström's macroglobulinemia, a rare type of lymphoma characterized by the overproduction of immunoglobulin M (IgM) antibodies. This medication works by disrupting the signals that allow malignant cells to thrive. Patients with Waldenström's may find that Imbruvica helps manage symptoms and improve their quality of life. The targeted approach of Imbruvica can lead to significant reductions in IgM levels.
• Healthcare providers often prescribe Imbruvica 140 mg capsule for patients with relapsed or refractory conditions, meaning their cancer has returned or is resistant to other treatments. This medication's unique mechanism of action allows it to be effective in these difficult cases. By offering a new line of defense, Imbruvica can help restore hope for patients facing challenging diagnoses. Its ability to target specific pathways makes it a crucial part of modern cancer therapy.
Benefits
Imbruvica 140 mg Capsule helps in treating blood cancer in patients who were not able to recover from previous medications. It helps to prevent the cancer cells to grow and multiply.
Side Effects
Like all medicines, this medicine can cause side effects, although not everybody gets them. The following side effects may happen with this medicine:
Most Common Side Effects
• Swollen feet and ankle
• Body pain Blurred Vision
• Vomiting
• Nausea
• Pneumonia
• Bloody Urine
• Constipation
• Breathlessness
• Bruises and Rashes
• Tiredness
• Numbness and Weakness
• Mouth Sores
Common Side Effects
• Low Count of Blood Cells
• High Blood Pressure
• Tumor Lysis Syndrome
• Allergic Reactions
• Infections
• Heart Problems
How To Use
Imbruvica 140 mg Capsule can be taken without or with food, as advised by your doctor. You must follow every guideline of your doctor strictly to get the best results.
Safety Advice
Not Found